Overview
Figure, based in Palo Alto, United States, has raised $1B in a Series C round on Sep 16, 2025, with participation from Parkway Venture Capital. The company figure is the first-of-its-kind AI robotics company bringing a general purpose humanoid to life. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the machinery manufacturing sector, Figure is positioned to capitalize on growing demand for innovative solutions in this space. The company was founded in 2022 by Brett Adcock. Brett brings deep domain expertise and a track record of execution that attracted investor confidence in this round. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
This funding positions Figure as one to watch in the machinery manufacturing landscape. As the company scales, it will likely become an increasingly attractive partner — and customer — for B2B vendors looking to sell into well-funded, growth-stage companies. The post-raise window of 60-90 days is typically when startups are most receptive to new tools, services, and partnerships.
Why contact Figure now
Figure just closed $1B in Series C funding — which means they're actively scaling their team, upgrading their tech stack, and looking for vendors who can help them move fast. Companies at this stage typically make purchasing decisions within 60-90 days of closing a round. If you sell to machinery manufacturing companies, this is your window to reach out before competitors do.
Founders & Contacts
Investors
Company Facts
| Company | Figure |
| Amount Raised | $1B |
| Funding Round | Series C |
| Date Raised | Sep 16, 2025 |
| Founded | 2022 |
| Industry | Machinery Manufacturing |
| Founders | Brett Adcock |
| HQ Location | Palo Alto, United States |
Get Verified Founder Emails
Access verified email addresses and contact details for Figure's founders and thousands of other funded startups.
Start Free Trial